Related Experiment Video
Updated: Aug 9, 2026
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Immunodeficiencies caused by genetic defects in protein kinases
1Department of Pediatrics, University of Brescia, c/o Spedali Civili 25123, Brescia, Italy. notarang@master.cci.unibs.it
Current Opinion in Immunology
|August 1, 1996
Summary
Defects in ZAP-70 and JAK3 kinase cause severe combined immunodeficiency in humans and mice. These protein kinases are crucial for T-cell activation and differentiation.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Severe combined immunodeficiency (SCID) is a group of rare genetic disorders characterized by profound defects in the immune system.
- ZAP-70 (zeta-chain-associated protein kinase 70) and JAK3 (Janus kinase 3) are critical signaling molecules in lymphocyte development and function.
Purpose of the Study:
- To highlight the critical role of ZAP-70 and JAK3 kinase in T-cell differentiation and activation.
- To underscore the significance of these protein kinases in the context of severe combined immunodeficiency.
Main Methods:
- Review of human genetic studies identifying ZAP-70 and JAK3 defects in SCID patients.
- Analysis of murine models with targeted gene disruptions of ZAP-70 and JAK3 to assess immunodeficiency phenotypes.
Main Results:
- Human genetic defects in ZAP-70 and JAK3 kinase are established causes of severe combined immunodeficiency.
- Targeting ZAP-70 and JAK3 genes in mice results in significant immunodeficiency, mirroring human conditions.
Conclusions:
- ZAP-70 and JAK3 are indispensable for proper T-cell differentiation and activation.
- Understanding these kinase pathways is crucial for diagnosing and potentially treating T-cell-related immunodeficiencies.
Related Concept Videos
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:09Cytoskeletal Linker Proteins - Plakins
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...